These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33524524)

  • 21. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements.
    Cilurzo F; Musazzi UM; Franzé S; Selmin F; Minghetti P
    Drug Discov Today; 2018 Feb; 23(2):251-259. PubMed ID: 29030242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.
    van Riet-Nales DA; Schobben AF; Egberts TC; Rademaker CM
    Clin Ther; 2010 May; 32(5):924-38. PubMed ID: 20685501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric drug formulations: challenges and potential solutions.
    Nahata MC
    Ann Pharmacother; 1999 Feb; 33(2):247-9. PubMed ID: 10084423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized Medicine in Pediatrics: The Clinical Potential of Orodispersible Films.
    Visser JC; Woerdenbag HJ; Hanff LM; Frijlink HW
    AAPS PharmSciTech; 2017 Feb; 18(2):267-272. PubMed ID: 27044380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop.
    Harris D; Hermans E; Klein S; Wagner-Hattler L; Walsh J
    Eur J Pharm Biopharm; 2020 Aug; 153():222-225. PubMed ID: 32580052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric formulation development - Challenges of today and strategies for tomorrow: Summary report from M-CERSI workshop 2019.
    Tan DCT; Khong YM; Mount S; Galella E; Mitra B; Charlton S; Kuhli M; Ternik R; Walsh J; Rajapakshe A; Thompson K; Mehrotra S; Santangelo M; Liu J; Dixit T; Schaufelberger D; Jamzad S; Klein S; Hoag SW; Wang J; Fletcher EP; Khurana M; Alexander J; Radden E; Sood R; Selen A
    Eur J Pharm Biopharm; 2021 Jul; 164():54-65. PubMed ID: 33878432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral dosage forms and drug delivery systems: tablets, oral films, liquid dosage forms, oral bioavailability enhancement.
    Alany R
    Pharm Dev Technol; 2017 Mar; 22(2):137. PubMed ID: 28178908
    [No Abstract]   [Full Text] [Related]  

  • 29. Devices for securing and administering pediatric compounded oral liquids: survey results from French university hospitals.
    Cavelier M; Hervouët C; Varin R; Gondé H
    Eur J Pediatr; 2024 Jun; 183(6):2805-2810. PubMed ID: 38573361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-Appropriate Pediatric Dosage Forms in Japan: Insights into End-User Perceptions From an Observational Cross-Sectional Survey Assessing the Acceptability of Oral Formulation.
    Saito J; Akabane M; Komura M; Nakamura H; Ishikawa Y
    Ther Innov Regul Sci; 2019 Jul; 53(4):455-471. PubMed ID: 30157669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric drug data in Canadian drug monographs: a descriptive analysis.
    Raja P; Duffett M; Mazer-Amirshahi M; Patel A; Gilpin A; Litalien C; Chan AK; van den Anker J; Lacaze-Masmonteil T; Samiee-Zafarghandy S
    CMAJ Open; 2020; 8(3):E522-E529. PubMed ID: 32873580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral delivery of peptide therapeutics in infants: Challenges and opportunities.
    Gleeson JP; Fein KC; Whitehead KA
    Adv Drug Deliv Rev; 2021 Jun; 173():112-124. PubMed ID: 33774115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
    Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
    Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral medicines for children in the European paediatric investigation plans.
    van Riet-Nales DA; Römkens EG; Saint-Raymond A; Kozarewicz P; Schobben AF; Egberts TC; Rademaker CM
    PLoS One; 2014; 9(6):e98348. PubMed ID: 24897509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
    Comoglu T; Dilek Ozyilmaz E
    Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Development of Levothyroxine Sodium Orodispersible Mini Tablets for the Treatment of Pediatrics Hypothyroidism.
    Henestrosa C; Olivera C; Flor S; Lucangioli S; Vacatello A; Ortega CA; Favier LS; Cifuente DA
    Recent Adv Drug Deliv Formul; 2023 Sep; ():. PubMed ID: 37723959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hot Melt Extruded and Injection Moulded Dosage Forms: Recent Research and Patents.
    Major I; McConville C
    Recent Pat Drug Deliv Formul; 2015; 9(3):194-200. PubMed ID: 27165308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buccal Dosage Forms: General Considerations for Pediatric Patients.
    Montero-Padilla S; Velaga S; Morales JO
    AAPS PharmSciTech; 2017 Feb; 18(2):273-282. PubMed ID: 27301872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.